SNIP1 Activators encompass a diverse set of chemical compounds that indirectly potentiate the functional activity of SNIP1 through multifaceted signaling pathways. For instance, Forskolin, by increasing cAMP levels, indirectly augments SNIP1's transcriptional regulation by facilitating PKA-mediated phosphorylation. Similarly, Rolipram and Zaprinast elevate intracellular cAMP and cGMP concentrations, respectively, leading to PKA activation which can phosphorylate and enhance SNIP1 activity. The differential kinase inhibition by Epigallocatechin gallate and Genistein can lessen the phosphorylation of competing transcriptional regulators, thereby indirectly potentiating SNIP1's regulatory functions. The modulation of calcium signaling with compounds like Ionophore A23187 and Thapsigargin can trigger the activation of calcium-dependent kinases that might contribute to the phosphorylation and subsequent enhancement of SNIP1's functional role. Furthermore, the activation of PKC by PMA could lead to a cascade of phosphorylation events benefiting SNIP1's transcriptional activities.
Alterations in intracellular signaling pathways by specific such as LY294002, U0126, and SB203580 indirectly facilitate SNIP1 activation. LY294002's inhibition of PI3K, U0126's targeting of MEK1/2, and SB203580's blockade of p38 MAPK can shift cellular signaling dynamics, thereby enhancing pathways that relyon SNIP1's involvement. The selective inhibition of these pathways allows for a compensatory increase in the activities where SNIP1 is a critical mediator, such as in transcriptional regulation. Additionally, the lipid signaling modulator Sphingosine-1-phosphate can enhance SNIP1 activity by engaging in signaling cascades that ultimately potentiate transcriptional regulation processes. Collectively, these SNIP1 Activators operate through a series of intracellular modifications and kinase interactions, leading to an upsurge in SNIP1's activity without directly increasing its expression levels or requiring direct activators, ensuring that SNIP1's regulatory functions are amplified within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, which increases cAMP levels in cells. Elevated cAMP activates PKA, which can phosphorylate SNIP1, enhancing its activity in its role as a transcriptional regulator. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits a range of kinases, thereby potentially reducing the phosphorylation of proteins that may compete with SNIP1 for binding to transcriptional machinery, thus indirectly enhancing SNIP1 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
The calcium ionophore A23187 increases intracellular calcium concentration. Increased calcium can activate calmodulin-dependent kinases which can phosphorylate SNIP1, thereby enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can lead to the phosphorylation of transcriptional regulators. This may enhance SNIP1's ability to interact with other proteins and DNA, increasing its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate receptor activation can lead to a cascade effect that activates MAPK and AKT signaling pathways, which can enhance SNIP1's transcription regulatory functions. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, thereby preventing cAMP degradation. Higher cAMP levels lead to activation of PKA, which can enhance SNIP1's activity by phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter the PI3K/AKT pathway. This alteration can shift cellular balance towards pathways where SNIP1 is active, thus indirectly enhancing its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. Inhibition of p38 MAPK can result in the redirection of cellular signaling towards pathways where SNIP1 functions are required, thereby potentially enhancing its activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By inhibiting competitive signaling routes, it may enhance SNIP1's role in transcription regulation due to reduced competitive inhibition. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, which can lead to the activation of signaling pathways involving calcium-dependent kinases that can phosphorylate and enhance SNIP1 activity. | ||||||